Obtaining of uterine vacuity in pregnancy loss;Obtention de la vacuité utérine dans le cadre d'une perte de grossesse

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 43, Issue 10, 2014, Pages 794-811

  Beucher, G ^a   Dolley, P ^a   Stewart, Z ^a,b   Lavoue V ^c   Deffieux, X ^d,e   Dreyfus, M ^a,b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Chirurgical uterineevacuation; Early miscarriage; Early pregnancyfailure; Fetal loss; Labor induction; Late intrauterinefetal death; Misoprostol; Pregnancy loss; Pregnancytermination; Stillbirth

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ARTICLE; BLOOD TRANSFUSION; CESAREAN SECTION; CURETTAGE; DILATION AND EVACUATION; FETUS DEATH; GESTATIONAL AGE; HUMAN; HYSTEROSCOPY; LABOR INDUCTION; MISSED ABORTION; PREGNANCY DISORDER; PREGNANCY LOSS; RISK ASSESSMENT; SURGICAL TECHNIQUE; UTERINE VACUITY; UTERUS FUNCTION; ABORTION, SPONTANEOUS; FEMALE; FIRST TRIMESTER PREGNANCY; PRACTICE GUIDELINE; PREGNANCY; STANDARDS;

ABORTION, SPONTANEOUS; FEMALE; FETAL DEATH; HUMANS; LABOR, INDUCED; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 84919970720     PISSN: 03682315     EISSN: 17730430     Source Type: Journal    
DOI: 10.1016/j.jgyn.2014.09.013     Document Type: Article

References (76)

1. NICE Clinical Guideline. Ectopic pregnancy and miscarriage: diagnosis and initial management in early pregnancy of ectopicpregnancy and miscarriage. National Collaborating Centre forWomen's and Children's Health. London: RCOG; 2012.
2. Graziosi GCM, Mol BW, Ankum WM, Bruinse HW. Managementof early pregnancy loss. Int J Gynecol Obstet 2004; 86: 337-46.
3. Neilson JP, Hickey M, Vazquez J. Medical treatment for earlyfetal death (less than 24 weeks). Cochrane Database Syst Rev2006: CD002253.
4. Sotiriadis A, Makrydimas G, Papatheodorou S, Ioannidis JPA. Expectant, medical or surgical management of firsttrimester miscarriage: a meta-analysis. Obstet Gynecol2005; 105: 1104-13.
5. Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical or surgical?Results of randomised controlled trial (miscarriage treatment[MIST] trial). BMJ 2006; 332: 1235-40.
6. Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM. A comparison of medical management withmisoprostol and surgical management for early pregnancy fai-lure. N England J Med 2005; 353: 761-9.
7. Nanda K, Lopez LM, Grimes DA, Peloggia A, Nanda G. Expec-tant care versus surgical treatment for miscarriage. CochraneDatabase Syst Rev 2012: CD003518.
8. Luise C, Jermy K, May C, Costello G, Collins WP, Bourne TH. Out-come of expectant management of spontaneous first trimestermiscarriage: obsvervational study. BMJ 2002; 324: 873-5.
9. Torre A, Huchon C, Bussieres L, Machevin E, Camus E, Faucon-nier A. Immediate versus delayed medical treatment for firsttrimester miscarriage: a randomized trial. Am J Obstet Gynecol2013; 206: 215 [e1-6].
10. May W, Gülmezoglu AM, Ba-Thike K. Antibiotics for incompleteabortion. Cochrane Database Syst Rev 2007; 17: CD001779.
11. Titapant V, Cherdchoogieat P. Effectiveness of cefoxitin on pre-venting endometritis after uterine curettage for spontaneousincomplete abortion: a randomized controlled trial study. JMed Assoc Thai 2012; 95: 1372-7.
12. Beucher G, Dolley P, Carles G, Salaun F, Asselin I, Dreyfus M. Misoprostol: utilisation hors AMM au premier trimestre dela grossesse (fausses couches spontanées, interruptions médi-cales et volontaires de grossesse). J Gynecol Obstet Biol Reprod2014; 43: 123-45.
13. Lister MS, Shaffer LE, Bell JG, Lutter KQ, Moorma KH. Ran-domized, double-blind, placebo-controlled trial of vaginalmisoprostol of early pregnancy failures. Am L Obstet Gynecol2005; 193: 1338-43.
14. Tang OS, Lau WNT, Ng EHY, Lee SWH, Ho PC. A prospectiverandomized study to compare the use of repeated doses ofvaginal with sublingual misoprostol in the management of firsttrimester silent miscarriage. Human Reprod 2003; 18: 176-81.
15. Tang OS, Ong CY, Tse KY, Ng EH, Lee SW, Ho PC. A ran-domized trial to compare the use of sublingual misoprostolwith or without an additional 1 week course for the mana-gement of first trimester silent miscarriage. Hum Reprod2006; 21: 189-92.
16. Odeh M, Tendler R, Kais M, Maximovsky O, Ophir E, Bornstein J. Early pregnancy failure: factors affecting successful medicaltreatment. Isr Med Assoc J 2010; 12: 325-8.
17. Creinin MD, Huang X, Westhoff C, Barnhart K, Gilles JM, Zhang J. Factors related to successful misoprostol treatment for earlypregnancy failure. Obstet Gynecol 2006; 107: 901-7.
18. Robledo C, Zhang J, Troendle J, Barnhart K, Creinin MD, Wes-Thoff C, et al. Clinical indicators for success of misoprostoltreatment after early pregnancy failure. Int J Gynaecol Obstet2007; 99: 46-51.
19. Reynolds A, Ayres-de-Campos D, Costa MA, Montenegro N. Howshould success be defined when attempting medical resolutionof first trimester missed abortion? Eur J Obstet Gynecol ReprodBiol 2005; 118: 71-6.
20. Gronlund A, Grønlund L, Clevin L, Andersen B, Palmgren N, Lidegaard Ø. Management of missed abortion: comparison ofmedical treatment with either mifepristone + misoprostol ormisoprostol alone with surgical evacuation. A multicenter trialin Copenhagen county, Denmark. Acta Obstet Gynecol Scand2002; 81: 1060-5.
21. Stockheim D, Machtinger R, Wiser A, Dulitzky M, Soriano D, Goldenberg M, et al. A randomized prospective study of miso-prostol or mifepristone followed by misoprostol when neededfor the treatment of women with early pregnancy failure. FertilSteril 2006; 86: 956-60.
22. Kollitz KM, Meyn LA, Lohr PA, Creinin MD. Mifepristone andmisoprostol for early pregnancy failure: a cohort analysis. AmJ Obstet Gynecol 2011; 204: 386 [e1-6].
23. Davis AR, Hendlish SK, Westhoff C, Frederick MM, Zhang J, Gilles JM, et al. Bleeding patterns after misoprostol vs. surgicaltreatment of early pregnancy failure: results from a randomi-zed trial. Am J Obstet Gynecol 2007; 196: 31 [e1-7].
24. Chen BA, Reeves MF, Creinin MD, Gilles JM, Barnhart K, Wes-Thoff CW, et al. Misoprostol for treatment of early pregnancyfailure in women with previous uterine surgery. Am J ObstetGynecol 2008; 198: 626 [e1-5].
25. Kong GW, Lok IH, Yiu AK, Hui AS, Lai BP, Chung TK. Clinicaland psychological impact after surgical, medical or expectantmanagement of first trimester miscarriage-a randomisedcontrolled trial. Aust N Z J Obstet Gynaecol 2013; 53: 170-7.
26. Rausch M, Lorch S, Chung K, Frederick M, Zhang J, Barnhart K. A cost-effectiveness analysis of surgical versus medical mana-gement of early pregnancy loss. Fertil Steril 2012; 97: 355-60.
27. Graziosi GC, van der Steeg JW, Reuwer PH, Drogtrop AP, Bruinse HW, Mol BW. Economic evaluation of misoprostol in the treat-ment of early pregnancy failure compared to curettage afteran expectant management. Hum Reprod 2005; 20: 1067-71.
28. Kauff ND, Chelmow D, Kawada CY. Intractable bleedingmanaged with Foley catheter tamponade after dilation andevacuation. Am J Obstet Gynecol 1995; 173: 957-8.
29. Olamijulo J, Doufekas K. Intrauterine balloon tamponade foruncontrollable bleeding during first trimester surgical termi-nation of pregnancy. J Obstet Gynaecol 2007; 27: 440-1.
30. Madden T, Burke A. Successful management of second trimes-ter postabortion hemorrhage with an intrauterine tamponadeballoon. Obstet Gynecol 2009; 113: 501-3.
31. Borgatta L, Chen AY, Reid SK, Stubblefield PG, Christensen DD, Rashbaum WK. Pelvic embolization for treatment of hemor-rhage related to spontaneous and induced abortion. Am JObstet Gynecol 2001; 185: 530-6.
32. Haddad L, Delli-Bovi L. Uterine artery embolization to treathemorrhage following second trimester abortion by dilatationand surgical evacuation. Contraception 2009; 79: 452-5.
33. Steinauer JE, Diedrich JT, Wilson MW, Darney PD, Vargas JE, Drey EA. Uterine artery embolization in postabortion hemor-rhage. Obstet Gynecol 2008; 111: 881-9.
34. Casikar I, Bignardi T, Riemke J, Alhamdan D, Condous G. Expec-tant management of spontaneous first trimester miscarriage: prospective validation of the two-week rule. Ultrasound ObstetGynecol 2010; 35: 223-7.
35. Casikar I, Lu C, Oates J, Bignardi T, Alhamdan D, Condous G. The use of power Doppler colour scoring to predict successfulexpectant management in women with an incomplete miscar-riage. Hum Reprod 2012; 27: 669-75.
36. Verschoor MA, Lemmers M, Bossuyt PM, Graziosi GC, Hajenius PJ, Hendriks DJ, et al. Surgical versus expectant managementin women with an incomplete evacuation of the uterus aftertreatment with misoprostol for miscarriage: the MisoREST trial. BMC Pregnancy Childbirth 2013; 13: 102.
37. Neilson JP, Gyte GM, Hickey M, Vazquez, Dou L. Medicaltreatments for incomplete miscarriage (less than 24 weeks). Cochrane Database Syst Rev 2013: CD007223.
38. Tunçalp O, Gulmezoglu AM, Souza JP. Surgical procedures toevacuating incomplete abortion. Cochrane Database Syst Rev2010: CD001993.
39. Smith LFP, Ewings PD, Quinlan C. Incidence of pregnancyafter expectant, medical, or surgical management of spon-taneous first trimester miscarriage: long-term follow-up ofmiscarriage treatment (MIST) randomised controlled trial. BMJ2009; 339: b3827.
40. Tam WH, Tsui MH, Lok IH, Yip SK, Yuen PM, Chung TK. Long-term reproductive outcome subsequent to medical ver-sus surgical treatment for miscarriage. Hum Reprod 2005; 20: 3355-9.
41. Hooker AB, Lemmers M, Thurkow AL, Heymans MW, OpmeerBC, Brölmann HA, et al. Systematic review and meta-analysis ofintrauterine adhesions after miscarriage: prevalence, risk fac-tors and long-term reproductive outcome. Hum Reprod Update2014; 20: 262-78.
42. Van den Bosch T, Daemen A, Van Schoubroeck D, Pochet N, De Moor B, Timmerman D. Occurrence and outcome of resi-dual trophoblastic tissue: a prospective study. J Ultrasound Med2008; 27: 357-61.
43. Cohen SB, Kalter-Ferber A, Weisz BS, Zadel Y, Seidman DS, Maschiach S, et al. Hysteroscopy may be the method of choicefor management of residual trophoblastic tissue. J Am AssocGynecol Laparosc 2001; 8: 199-202.
44. Rein DT, Schmidt T, Hess AP, Volkmer A, Schondorf T, Breiden-bach M. Hysteroscopic management of residual trophoblastictissue is superior to ultrasound-guided curettage. J Minim Inva-sive Gynecol 2011; 18: 774-8.
45. Royal College of Obstetricians and Gynaecologists. Late intrau-terine fetal death and stillbirth. RCOG guideline No. 55. London: RCOG Press; 2010.
46. Bryant AG, Grimes DA, Garrett JM, Stuart GS. Second tri-mester abortion for fetal anomalies or fetal death: laborinduction compared with dilation and evacuation. Obstet Gyne-col 2011; 117: 788-92.
47. Kelly T, Suddes J, Howel D, Hewison J, Robson S. Com-paring medical versus surgical termination of pregnancy at13-20 weeks of gestation: a randomised controlled trial. BJOG2010; 117: 1512-20.
48. Chasen ST, Kalish RB, Gupta M, Kaufman J, Chervenak FA. Obstetric outcomes after surgical abortion at > or = 20 weeks'gestation. Am J Obstet Gynecol 2005; 193: 1161-4.
49. Jackson JE, Grobman WA, Haney E, Casele H. Mid-trimesterdilation and evacuation with laminaria does not increase therisk for severe subsequent pregnancy complications. Int JGynaecol Obstet 2007; 96: 12-5.
50. Dodd JM, Crowther CA. Misoprostol for induction of labourto terminate pregnancy in the second or third trimester forwomen with a fetal anomaly or after intrauterine fetal death. Cochrane Database Syst Rev 2010: CD004901.
51. Pluchon M, Winer N. Misoprostol dans les IMG aux 2eet 3etrimestres. Essais comparatifs. J Gynecol Obstet Biol Reprod2014; 43: 162-8.
52. Marret H, Simon E, Beucher G, Dreyfus M, Gaudineau A, Vays-sière C, et al. États des lieux et expertise de l'usage hors AMMdu misoprostol en gynécologie-obstétrique: travail du CNGOF. J Gynecol Obstet Biol Reprod 2014; 43: 107-13.
53. Clouqueur E, Coulon C, Vasst P, Chauvet A, Deruelle P, SubtilD, et al. Utilisation du misoprostol pour l'induction du travailen cas de MIU ou d'IMG au deuxième ou au troisième trimestrede la grossesse: efficacité, posologie, voie d'administration, effets secondaires, utilisation en cas d'utérus cicatriciel. JGynecol Obstet Biol Reprod 2014; 43: 146-61.
54. Eng NS, Guan AC. Comparative study of intravaginal misopros-tol with gemeprost as an abortifacient in second trimestermissed abortion. Aust N Z J Obstet Gynaecol 1997; 37: 331-4.
55. Nakintu N. A comparative study of vaginal misoprostol andintravenous oxytocin for induction of labour in women withintra uterine fetal death in Mulago Hospital, Uganda. Afr HealthSci 2001; 1: 55-9.
56. Chittacharoen A, Herabutya Y, Punyavachira P. A randomizedtrial of oral and vaginal misoprostol to manage delivery in casesof fetal death. Obstet Gynecol 2003; 101: 70-3.
57. Fadalla FA, Mirghani OA, Adam I. Oral misoprostol vs. vagi-nal misoprostol for termination of pregnancy with intrauterinefetal demise in the second trimester. Int J Gynecol Obstet2004; 86: 52-3.
58. Nyende L, Towobola OA, Mabina MH. Comparison of vaginal andoral misoprostol, for the induction of labour in women withintrauterine fetal death. East Afri Med J 2004; 81: 179-82.
59. Caliskan E, Dilbaz S, Doger E, Ozeren S, Dilbaz B. Randomizedcomparison of 3 misoprostol protocols for abortion inductionat 13-20 weeks of gestation. J Reprod Med 2005; 50: 173-80.
60. Niromanesh S, Hashemi-Fesharaki M, Mosavi-Jarrahi A. Secondtrimester abortion using intravaginal misoprostol. Int J Gynae-col Obstet 2005; 89: 276-7.
61. Van Mensel K, Claerhout F, Debois P, Keirse MJ, Hanssens M. A randomized controlled trial of misoprostol and sulpros-tone to end pregnancy after fetal death. Obstet Gynecol Int2009: 496320, http://dx.doi.org/10.1155/2009/496320.
62. Bracken H, Ngoc NT, Banks E, Blumenthal PD, Derman RJ, Patel A, et al. Buccal misoprostol for treatment of fetal death at14-28 weeks of pregnancy: a double-blind randomized control-led trial. Contraception 2014; 89: 187-92.
63. Wagaarachchi PT, Ashok PW, Narvekar NN, Smith NC, Tem-pleton A. Medical management of late intrauterine deathusing a combination of mifepristone and misoprostol. BJOG2002; 109: 443-7.
64. Fairley TE, Mackenzie M, Owen P, Mackenzie F. Management oflate intrauterine death using a combination of mifepristone andmisoprostol-experience of two regimens. Eur J Obstet GynecolReprod Biol 2005; 118: 28-31.
65. Sharma D, Singhal SR, Poonam, Paul A, Kunik A. Comparisonof mifepristone combination with misoprostol and misoprostolalone in the management of intrauterine death: condensation- misoprostol and mifepristone combination is more effec-tive than misoprostol alone in the management of intrauterinedeath. Taiwan J Obstet Gynecol 2011; 50: 322-5.
66. Gómez Ponce de León R, Wing DA. Misoprostol for terminationof pregnancy with intrauterine fetal demise in the second andthird trimester of pregnancy-a systematic review. Contra-ception 2009; 79: 259-71.
67. Jain JK, Mishell Jr DR. A comparison of intravaginal misopros-tol with prostaglandin E2 for termination of second trimesterpregnancy. N Engl J Med 1994; 331: 290-3.
68. Makhlouf AM, Al-Hussaini TK, Habib DM, Makarem MH. Secondtrimester pregnancy termination: comparison of three dif-ferent Methods J Obstet Gynecol 2003; 23: 407-11.
69. Hidar S, Fekih M, Chaieb A, Bibi M, Mellouli R, Khairi H. Apport de l'association d'ocytocine au misoprostol administréen intravaginal au cours des interruptions de grossesses entre13 et 29 semaines d'aménorrhée. Essai clinique prospectif ran-domisé. J Gynecol Obstet Biol Reprod 2001; 30: 439-43.
70. Jain JJ, Mishell DR. A comparison of misoprostol with andwithout laminaria tents for induction of second trimester abor-tion. Am J Obstet Gynecol 1996; 175: 173-7.
71. Newmann SJ, Dalve-Endres A, Diedrich JT, Steinauer JE, Meckstroth K, Drey EA. Cervical preparation for second tri-mester dilation and evacuation. Cochrane Database Syst Rev2010; 8: CD007310.
72. Lurie S, Blickstein I, Feinstein M, Matzkel A, Ezri T, Soroker D. Influence of epidural anaesthesia on the course of labourin patients with antepartum fetal death. Aust N Z J ObstetGynaecol 1991; 31: 227-8.
73. Leader J, Bujnovsky M, Carlan SJ, Triana T, Richichi K. Effect oforal misoprostol after second trimester delivery: a randomized, blinded study. Obstet Gynecol 2002; 100: 689-94.
74. Green J, Borgatta L, Sia M, Kapp N, Saia K, Carr-Ellis S, et al. Intervention rates for placental removal following inductionabortion with misoprostol. Contraception 2007; 76: 310-3.
75. Dickinson JE, Evans SF. A comparison of oral misoprostolwith vaginal misoprostol administration in second trimesterpregnancy termination for fetal abnormality. Obstet Gynecol2003; 101: 1294-9.
76. Deruelle P, Lepage J, Depret S, Clouqueur E. Mode de déclen-chement du travail et conduite du travail en cas d'utéruscicatriciel. J Gynecol Obstet Biol Reprod 2012; 41: 788-802.